Triste, Sherlyn B.

HRN: 04-46-44  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/21/2025
06/27/2025
IV
1.5g
Q8
Infected Breast Mass
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: